Abhishek Pandey, PhD
Cards
About
Research
Overview
Public Health Interests
Vaccines; Global Health; Conflict and Health; Infectious Diseases; Modeling
Publications
2025
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nat Med 2025, 31: 647-652. PMID: 39789324, DOI: 10.1038/s41591-024-03431-7.Peer-Reviewed Original ResearchHarnessing the potential of human immunodeficiency virus self-testing to bolster pre-exposure prophylaxis uptake and achieve UNAIDS targets in sub-Saharan Africa
Galvani-Townsend S, Pandey A. Harnessing the potential of human immunodeficiency virus self-testing to bolster pre-exposure prophylaxis uptake and achieve UNAIDS targets in sub-Saharan Africa. Ann Infect 2025;9:1.Commentaries, Editorials and LettersIntegrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges.
Ye Y, Pandey A, Bawden C, Sumsuzzman DM, Rajput R, Shoukat A, Singer BH, Moghadas SM, Galvani AP. Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges. Nat Commun 2025, 16: 581. PMID: 39794317, DOI: 10.1038/s41467-024-55461-x.Peer-Reviewed Original Research
2024
Estimating the lives that could be saved by expanded access to weight-loss drugs
Pandey A, Ye Y, Wells C, Singer B, Galvani A. Estimating the lives that could be saved by expanded access to weight-loss drugs. Proceedings Of The National Academy Of Sciences Of The United States Of America 2024, 121: e2412872121. PMID: 39405358, PMCID: PMC11513960, DOI: 10.1073/pnas.2412872121.Peer-Reviewed Original ResearchConceptsGlucagon-like peptide-1Body mass index categoriesObesity prevalence dataGlucagon-like peptide-1 receptor agonistsHazard ratio of mortalityRatio of mortalityPublic health impactWeight loss drugsInsurance coverage issuesGastric inhibitory polypeptideHealthcare accessType 2 diabetesUnited StatesPublic health crisisObesity epidemicReceptor agonistsIndex categoriesHazard ratioPrevalence dataInhibitory polypeptidePeptide-1Health impactsNovel treatmentObesityHealth crisisMortality and morbidity ramifications of proposed retractions in healthcare coverage for the United States
Pandey A, Fitzpatrick M, Singer B, Galvani A. Mortality and morbidity ramifications of proposed retractions in healthcare coverage for the United States. Proceedings Of The National Academy Of Sciences Of The United States Of America 2024, 121: e2321494121. PMID: 38648491, PMCID: PMC11066981, DOI: 10.1073/pnas.2321494121.Peer-Reviewed Original ResearchEvaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
Wells C, Pandey A, Moghadas S, Fitzpatrick M, Singer B, Galvani A. Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States. Annals Of Internal Medicine 2024, 177: 609-617. PMID: 38527289, DOI: 10.7326/m23-2451.Peer-Reviewed Original ResearchSARS-CoV-2 vaccination campaignSARS-CoV-2Centers for Disease Control and PreventionDisease Control and PreventionSARS-CoV-2 vaccinesHealth care costsVaccine-acquired immunityFood and Drug AdministrationU.S. Food and Drug AdministrationControl and PreventionNational Institutes of HealthVaccination campaignInfluenza vaccineInitial doseInstitutes of HealthSARS-CoV-2 variantsBooster doseImmune evasionDrug AdministrationUnited StatesNotsew Orm Sands FoundationDoseHealthPopulation immunityNational InstituteA Generalizable Theory-Driven Agent-Based Framework to Study Conflict-Induced Forced Migration
Mehrab Z, Stundal L, Venkatramanan S, Swarup S, Lewis B, Mortveit H, Barrett C, Pandey A, Wells C, Galvani A, Singer B, Moghadas S, Leblang D, Colwell R, Marathe M. A Generalizable Theory-Driven Agent-Based Framework to Study Conflict-Induced Forced Migration. Proceedings Of The AAAI Conference On Artificial Intelligence 2024, 38: 23027-23033. DOI: 10.1609/aaai.v38i21.30345.Peer-Reviewed Original ResearchAgent-based frameworkForced migrationGraph dynamical systemsPolicy implicationsConflict-induced migrationLarge-scale population displacementMigration outflowPolicy challengesComputational frameworkSpatial granularityPopulation displacementSocial theoryConflict settingsRussian forcesModeling frameworkCivilian populationSocial sciencesPolicyAn agent-based framework to study forced migration: A case study of Ukraine
Mehrab Z, Stundal L, Venkatramanan S, Swarup S, Lewis B, Mortveit H, Barrett C, Pandey A, Wells C, Galvani A, Singer B, Leblang D, Colwell R, Marathe M. An agent-based framework to study forced migration: A case study of Ukraine. PNAS Nexus 2024, 3: pgae080. PMID: 38505694, PMCID: PMC10949908, DOI: 10.1093/pnasnexus/pgae080.Peer-Reviewed Original ResearchForced migrationOutflow of migrantsCase study of UkraineStudy of UkraineDeliver humanitarian assistanceMigration flowsHumanitarian assistanceHumanitarian resourcesPolicy-makersConflict eventsPolicymaker uncertaintyPolicy questionsRussian aggressionCrisis settingsUkraine warConflictPolicyConflict scenariosUkraineCase studyMigrantsMigrationBehavioral theoryWarCrisis
2023
Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City
Pandey A, Fitzpatrick M, Moghadas S, Vilches T, Ko C, Vasan A, Galvani A. Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City. The Lancet Regional Health - Americas 2023, 24: 100555. PMID: 37554154, PMCID: PMC10405058, DOI: 10.1016/j.lana.2023.100555.Peer-Reviewed Original ResearchHealthcare costsVaccine dosesInfluenza vaccine coverageCOVID-19 illnessDirect healthcare costsSevere health outcomesCOVID-19 vaccineCOVID-19 burdenNew York CityBooster vaccineVaccine coverageVaccination ratesBivalent vaccineBase case scenarioHealth outcomesEligible residentsProbable casesDisease controlVaccineCanadian InstituteCOVID-19VaccinationHealth researchCommonwealth FundOutcomesEstimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination
Fitzpatrick M, Moghadas S, Vilches T, Shah A, Pandey A, Galvani A. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination. JAMA Network Open 2023, 6: e2313586. PMID: 37204795, PMCID: PMC10199352, DOI: 10.1001/jamanetworkopen.2023.13586.Peer-Reviewed Original ResearchConceptsBooster campaignBooster vaccinationInfluenza vaccinationPediatric populationDecision analytical modelSchool absenteeismIntensive carePediatric hospitalizationsEligible individualsMAIN OUTCOMEAge groupsIntensive care unit admissionCare unit admissionSeasonal influenza vaccinationCOVID-19 illnessCOVID-19 prevention strategiesEligible age groupDecreased hospitalizationsUnit admissionCOVID-19 transmissionSymptomatic infectionAdverse outcomesIsolation daysHospitalizationGeneral population
Academic Achievements & Community Involvement
News & Links
News
- October 16, 2024
Expanding Access to Weight-Loss Drugs Could Save Thousands of Lives A Year, Study Finds
- March 25, 2024Source: Healio
Study: Annual COVID-19 vaccine campaign with second dose reduces disease burden, costs
- July 28, 2022Source: The Commonwealth Fund
How Many Lives Could a Fall COVID-19 Booster Campaign Save in the United States?
- July 27, 2022
Traveling or considering a night on the town? Best time to test for COVID is right before you leave
Get In Touch
Contacts
Academic Office Number
Mailing Address
Epidemiology of Microbial Diseases
135 College Street, Rm 218
New Haven, CT 06510
United States
Locations
CIDMA
Academic Office
135 College Street, Ste 200, Rm 218
New Haven, CT 06510